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Abstract (150 words; 150 words max) 43 
 44 
Since recent research indicates that other modalities are at a minimum non-inferior to the NICE-45 
recommended hormonal agent prostaglandin E2 (PGE2), a retrospective cohort study was 46 
conducted on 1971 consecutive induced singleton pregnancies. Multinominal regression showed 47 
that the odds ratio (OR) for vaginal delivery with balloon-mediated labour induction (84% vaginal 48 
deliveries; OR 1.6; 95% CI 0.7-3.5) is similar to the PGE2 agents propess (81%; OR 1.2; 95% CI 0.68-49 
1.98) and prostin (79%; OR 0.99; 95% CI 0.55-1.79) when using triple multi-agent induction as a 50 
reference. On the other hand, combining propess & prostin (60% vaginal deliveries; OR 0.45; 95% 51 
CI 0.21-0.96) and attempting quadruple combinations of induction modalities (56%; OR 0.37; 95% 52 
CI 0.16-0.85) yield significantly poorer outcomes. However, compared to known factors associated 53 
with increased caesarean section rates, such as increased maternal age, nulliparous pregnancies 54 
and history of caesarean section, the differential impact of different induction modalities appears 55 
less pronounced.  56 
 57 
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Impact statement (184 words; 200 words max) 63 
• What is already known on this subject. 64 
Recent published data from controlled clinical trials have shown that other labour-inducing agents, 65 
including balloon catheters, are as effective as prostaglandin E2 (PGE2) in achieving vaginal delivery.  66 
• What the results of this study add. 67 
Data from this pragmatic retrospective cohort study support the findings of others that the use of a 68 
balloon is as effective as PGE2. It also demonstrates that regular clinical practice can differ from an 69 
experimental environment, with patients receiving multiple induction modalities in daily practice. 70 
Both the combination of different PGE2 medications  and a quadruple labour induction approach 71 
are associated with poorer results as measured by the vaginal delivery rate. The data presented 72 
here also confirms that nulliparous status, maternal age and history of caesarean section are 73 
associated with reduced odds of achieving vaginal delivery. 74 
• What the implications are of these findings for clinical practice and/or further research. 75 
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The body of evidence showing favourable results with balloon induction is growing. Furthermore, 76 
there are limits to the effectiveness of combining different induction modalities. Maternal and 77 
perinatal factors associated with risk of caesarean section further complicate labour induction 78 
management. 79 
80 
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 82 
Introduction 83 
The application of labour induction has been increasing year-on-year and is now applied in 84 
approximately 25% of pregnancies (NHS digital, 2015); in approximately two thirds of cases, 85 
unaided vaginal delivery is achieved (RCOG, 2008). Although induction of labour itself carries risks, 86 
the risk of caesarean delivery is 12% lower with induction compared to expectant management 87 
(Mishanina et al, 2014). Progesterone E2 (PGE2), as a vaginal pessary, gel, or tablet is currently the 88 
recommended mode of pharmacological induction according to National Institute for Health and 89 
Care Excellence Guidelines (NICE, 2008). In a previous study, we and others linked nulliparous 90 
status of a woman with increased use of PGE2, and increased risk of caesarean section - despite the 91 
fact that these patients are being administered more doses of PGE2 (Yogev et al, 2003; Memon et 92 
al, 2011). More recent research has shown that other modalities may be associated with non-93 
inferior or even better outcomes than PGE2 for labour induction. For example, a systematic review 94 
found that misoprostol leads to more timely vaginal deliveries compared to PGE2 (Alfirevic et al, 95 
2015). In another systematic review, Du et al (2017) showed that balloon-assisted induction of 96 
labour is as effective and safe as induction with PGE2. The positive evidence for balloons prompted 97 
NICE to publish an Interventional Procedures  98 
Guidance (NICE, 2015). This study aims to investigate how different induction methods for labour 99 
compare in terms of achieving vaginal delivery, using cases from a non-controlled standard clinical 100 
setting, based on local clinical guidelines devised from national published guidance.   101 
 102 
Materials & Methods 103 
Induction guidelines 104 
This concerns a retrospective cohort study of pregnant women managed by induction of labour in 105 
the maternity unit of a general district hospital in the UK, covering the period mid-July 2015 to end 106 
of July 2017. Multiple pregnancies were excluded, as were inductions related to planned 107 
terminations. All patients met the criteria for induction of pregnancy as outlined in our local clinical 108 
guidelines on induction labour. These guidelines draw from the main national and international 109 
literature, National Institute for health and Care Excellence (NICE, 2008, 2011, 2015, 2015); the 110 
Royal College of Obstetrics and Gynaecology (RCOG, 2014 & 2015) and the World Health 111 
Organisation (WHO, 2011). Some of the key reasons for induction and the primary mode of 112 
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induction in accordance to local guidelines are summarised in Table 1. Due to positive outcomes 113 
published in recent years concerning induction of labour with a balloon, and the interventional 114 
procedure guidance publication by NICE (2015), this modality was introduced in the department 115 
from 2016 onwards; the balloon model used is a Cook Cervical ripening balloon. If the Bishop score 116 
is over 7 then patients are considered eligible for direct artificial rupture of membranes (ARM). 117 
Patients undergoing induction of labour who do not show signs of labour after 24 hours from 118 
insertion of 10mg Propess pessary or after 2 doses of 3mg Prostin pessaries, medical staff assess 119 
and decide on further induction or Caesarean section. Intravenous oxytocin is not commenced until 120 
30 minutes after the 10mg Propess pessary has been removed or six hours have lapsed following 121 
the administration of a 3mg Prostin pessary. Oxytocin is only used in the presence of ruptured 122 
membranes, whether occurred spontaneously or by amniotomy.    123 
Data 124 
Data was collected in Microsoft Excel and analysed in SPSS v17. Multinominal regression analysis 125 
was conducted, with all variables included as factors in the analysis (all variables listed in Tables 2 & 126 
3). Unaided and aided vaginal deliveries were pooled and compared to births through caesarean 127 
section. Trials evaluating success of labour induction often focus on time to delivery and delivery 128 
within 24 hours (Faucett et al, 2014; Mishanina et al, 2014). In standard daily practice, clinical 129 
parameters such as maternal well-being and foetal monitoring data are used for decision-making 130 
on type of induction and whether to proceed with caesarean section; therefore, the time-related 131 
outcome measures were not applied in this study.    132 
 133 
Results  134 
A total of 1971 deliveries were included in the analyses; no maternal or foetal deaths occurred in 135 
this cohort. Table 2 summarises the demographics and obstetric medical history for the patients 136 
included. Furthermore, the extent to which each variable is associated with vaginal delivery is 137 
determined by multinominal regression analysis. Likewise, the primary reason for induction is 138 
summarised in Table 3, with the odds of vaginal delivery again assessed through multinominal 139 
regressional analysis. The most common reasons for induction of labour in this cohort were post-140 
term (i.e. > 41 weeks; 18.8%), small for gestational age (SGA; 14.4%) and pre-labour membrane 141 
rupture (12.6%) respectively. The mean average maternal age was 30 years (min 13 to max 46 142 
years), and median gravida and parity were 2 and 1 respectively. Mean weight of the newborn 143 
child was 3,384 grams; median blood loss was 300 ml. In terms of vaginal deliveries, 1342 (68.1%) 144 
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of these were unaided, in 238 (12.1%) cases an extraction technique such as forceps or vacuum 145 
had to be applied, and a caesarean section was required in 391 (19.8%) cases. This compares 146 
favourably compared to overall caesarean section rates of 26% in the UK in 2013-14.  147 
As identified previously by us and others (Yogev et al, 2003; Memon et al, 2011), parity is strongly 148 
linked with increased risk of caesarean section. Young maternal age on the other hand is positively 149 
associated with vaginal delivery. A previous caesarean section significantly increases the odds of 150 
patients requiring another one in future pregnancies, as confirmed in Table 2.  151 
Only pregnancies with proven abnormal readings on cardiotocograph (CTG) are linked with 152 
increased risk of caesarean section.  Reduced foetal movement, however, is not associated with 153 
any mode of delivery, whereas small for gestational age babies are linked with improved chance of 154 
vaginal delivery. Incidentally, there is limited guidance on the best mode of induction for 155 
presentations of reduced foetal movement. The RCOG guidance on reduced foetal movements 156 
(RCOG, 2011) states: ’the decision whether or not to induce labour at term in a woman who 157 
presents recurrently with RFM when the growth, liquor volume and CTG appear normal must be 158 
made after careful consultant-led counselling of the pros and cons of induction on an individualised 159 
basis’. 160 
Discussion 161 
When considering the primary variable of interest in relation to induction success, measured by 162 
percentage vaginal delivery (unaided and instrument-aided), three trends can be identified from 163 
the results in Table 3. Firstly, ARM is a very effective induction treatment compared to hormonal 164 
induction, but is only indicated and used in a subset of expectant mothers. Secondly, balloon 165 
catheter induced labour gives very similar outcomes to the use of either propess or prostin. Our 166 
data corroborates with the data published in the systematic review by Du et al on the use of 167 
balloon catheters (2017). Thirdly, it appears that combining the two PGE2 agents propess and 168 
prostin is counterproductive and associated with lower vaginal delivery rates. Furthermore, 169 
administering quadruple combinations of induction agents (for example propess, balloon, 170 
syntocinon and prostin) also gave poorer outcomes in terms of vaginal delivery rates. This practice 171 
is not in accordance with NICE guidelines and it also increases the risk of uterine hyperstimulation.  172 
This retrospective ‘snapshot’ of induction of labour has considerable drawbacks compared to a 173 
prospective controlled cohort or (randomised) trial design. These include variability in the choice of 174 
induction agent, often allowed in national guidelines, and inclusion of patients who normally would 175 
not be included in studies - particularly those who have a history of delivery by caesarean section. 176 
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However, conversely these shortcomings contribute to being able to gain an insight into how 177 
successful induction of labour is, in terms of vaginal delivery achieved, in a standard district 178 
hospital setting.  179 
Conclusion 180 
Our data shows that the established predictors, including increased maternal age, nulliparous 181 
pregnancies and history of caesarean section, are associated more significantly with increased 182 
caesarean section than the primary reason or chosen modality for labour induction (when non-183 
recommended induction methods are not taken into account). In conclusion, our data adds to the 184 
body of evidence that suggests that induction methods other than PGE2 may just as effective.  185 
 186 
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Table 1, Local clinical guideline on choice of modality for induction of labour 281 
 282 
Induction – primary reason or 
circumstances 
First line induction 
modality 
Second line induction 
modality 
Post-term (> 41 weeks) Prostin or Propess  
Diabetes (gestational, type I, 
type II) 
Prostin  Propess (only > 38 weeks 
gestation) 
Pre-labour rupture of 
membranes 
Prostin  
Small for Gestational Age 
Prostin  Propess (only > 38 weeks 
gestation) 
Reduced foetal movement   
Hypertension-related 
Prostin  Propess (only > 38 weeks 
gestation) 
Previous Caesarean section ARM Prostin or Balloon 
 283 
 284 
 285 
Table 2, Multinominal regression analysis of odds ratios associated with vaginal delivery, using 286 
caesarean section as reference – demographics and obstetric medical history 287 
 288 
Variable  Category N (vaginal / 
total)  
% (vaginal / 
total) 
Odds 
Ratio 
95% CI 
(lower) 
95% CI 
(upper) 
Maternal age  Under 24 243 / 292 83% 2.26* 1.44 3.56 
 24 to 30 538 / 655 82% 1.49* 1.04 2.16 
 30 to 35 463 / 574 81% 1.44 1.00 2.09 
 35 and over 311 / 408 76% 1   
Gravida 0 539 / 746 72% 1.22 0.73 2.02 
 1 491 / 583 84% 1.19 0.75 1.91 
 2 or more 525 / 600 88% 1   
Parity  0 677 / 944 72% 0.10* 0.045 0.24 
 1 493 / 561 88% 0.44* 0.20 0.95 
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 2 227 / 251 90% 0.60 0.27 1.35 
 3 or more 158 / 173 91% 1   
Previous 
stillbirth  
0 1533 / 
1903 
81% 
1.81 0.55 5.92 
 1 or more 22 / 26 85% 1   
Previous CS  0 1511 / 
1853 
82% 
11.37* 6.28 20.60 
 1 or more 44 / 76 58% 1   
Reference Pseudo R2 = 0.24 (Nagelkerke); *p < 0.05 289 
 290 
Table 3, Multinominal regression analysis of odds ratios associated with vaginal delivery, using 291 
caesarean section as reference – reason for, and method of induction  292 
 293 
 294 
Variable  Category N (vaginal / 
total)  
% (vaginal / 
total) 
Odds 
Ratio 
95% CI 
(lower) 
95% CI 
(upper) 
Induction – 
primary reason  Post-term 279 / 359 
78% 
0.78 0.517 1.18 
 Diabetes 145 / 190 76% 0.85 0.51 1.39 
 Pre-labour rupture 192 / 239 80% 1.19 0.70 2.01 
 SGA 249 / 279 89% 2.03* 1.20 3.44 
 Pre-eclampsia 60 / 83 72% 0.95 0.50 1.82 
 Other maternal 
reason 
183 / 235 
78% 
0.72 0.45 1.15 
 Reduced fetal 
movement 
158 / 182 
87% 
1.47 0.83 2.62 
 Other 285 / 356 80% 1   
Induction – 
method  Propess (PGE2) 606 / 749 
81% 
1.16 0.68 1.98 
 ARM 192 / 212 91% 2.56* 1.27 5.17 
 Prostin (PGE2) 294 / 371 79% 0.99 0.55 1.79 
 Syntocinon 
(oxytocin) 
54 / 74 
73% 
0.78 0.34 1.76 
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 Other single or 
dual method 
167 / 196 
85% 
1.44 0.75 2.79 
 Balloon 77 / 92 84% 1.61 0.74 3.48 
 Combination 
propress & prostin 
37 / 62 
60% 
0.45* 0.21 0.96 
 Quadruple or more 
combination 
23 / 41 
56% 
0.37* 0.16 0.85 
 Triple combination 99 / 123 80% 1   
Intrapartum 
foetal problems  None 
1017 / 
1167 
87% 
3.50* 1.96 6.25 
 Non-reassuring 
CTG 
295 / 357 
83% 
3.14* 1.68 5.85 
 Abnormal CTG 184 / 299 61% 0.98 0.54 1.81 
 Other 50 / 73 68% 1   
Reference Pseudo R2 = 0.24 (Nagelkerke); *p < 0.05 295 
 296 
 297 
 298 
 299 
 300 
 301 
 302 
 303 
 304 
 305 
 306 
 307 
 308 
 309 
 310 
 311 
 312 
 313 
 314 
 315 
